Search Results
Jun 09, 2026, 09:30 ET Lung Cancer Research Foundation Announces Request for Proposals Open for ALK-Positive Lung Cancer Research Grant
In 2007, scientists discovered that a genetic abnormality, or fusion, called EML4-ALK plays a key role in driving a subset of NSCLC. This led to the development of targeted drugs called ALK inhibitors, the first of which was FDA-approved
More news about: Lung Cancer Research Foundation
May 30, 2026, 16:15 ET AdvisorVault Adds Social Media Archiving to its Consolidated D3P Service
Capture & securely archive attachments, images, videos and audio filesExport tools for eDiscovery requests for auditors in .pst or .eml format immediatelyDynamic email alerts to compliance officers monitoring activity across social mediaAbout AdvisorVaultAdvisorVault
More news about: AdvisorVault
May 19, 2026, 09:30 ET Funding from Patients, Caregivers, Foundations and Industry Partners Fuels ALK-positive Research
long-term survival outcomes and quality of life for these patients.In 2007, scientists discovered that a genetic abnormality, or fusion, called EML4-ALK plays a key role in driving a subset of non-small cell lung cancers (NSCLC). This led to the development of targeted drugs called ALK inhibitors,
More news about: Lung Cancer Research Foundation
May 05, 2026, 09:00 ET Gold and Silver Markets Enter Powerful Growth Phase as Prices Target New Highs
operations.Emergent Metals Corp. Provides an Update on its Sale of the Golden Arrow Property, NV - Emergent Metals Corp. (TSXV: EMR) (OTCQB: EGMCF) (FRA: EML) (MUN: ELM) ("Emergent" or the "Company") announces that, further to the Company's news releases dated September 29, 2025, March 24, 2026 and April 10,
More news about: Market News Updates
Apr 23, 2026, 04:00 ET Attackers Favor Widely Trusted Platforms While Adapting to Detection Methods, VIPRE's Q1 2026 Email Threat Trends Report Reveals
methods.Likewise, attackers are increasingly using images as attachments with JPGs making up 6% and PNGs 4% to bypass text-based detection tools. EML files are also on the rise, with use in 13.15% of cases. By attaching entire emails, threat actors effectively mimic the format of genuine internal email
More news about: VIPRE Security Group
Apr 20, 2026, 07:00 ET Genprex Collaborators Present Positive Preclinical Data on the Use of Reqorsa® Gene Therapy for the Treatment of Lung Cancer at the 2026 AACR Annual Meeting
Predict Patient Response to Reqorsa® Gene TherapyREQORSA Induced Apoptosis and Decreased Tumor Volume in ALK-EML4 Positive Translocated Non-Small Cell Lung Cancer Cell Lines and In Vivo Mouse StudiesREQORSA Boosts Natural Killer (NK)
More news about: Genprex, Inc.
Mar 18, 2026, 09:30 ET Two Linktel 800G Dispersion Managed Transceivers Win 2026 Lightwave Innovation Awards
Powered by a 200G/lane CWDM EML design, this module achieved an exceptional BER of 1E-10 to 1E-11 and demonstrated Error-Free performance at 113 GBaud with FEC—a new standard for 800G campus networks.800G 2LR4+ 20km (Score: 4.0): Integrating a 100G/lane CWDM EML with a 4-channel DMD architecture,
More news about: Linktel Technologies
Mar 18, 2026, 07:00 ET Genprex Collaborators to Present Positive Preclinical Data on the Use of Reqorsa® Gene Therapy for the Treatment of Lung Cancer at the 2026 AACR Annual Meeting
Biomarkers that May Predict Patient Response to Reqorsa® Gene TherapyREQORSA is a Potential Treatment for ALK-EML4 Positive Translocated Non-Small Cell Lung CancerREQORSA Boosts Natural Killer (NK) Cell Antitumor Activity
More news about: Genprex, Inc.
Jan 21, 2026, 03:07 ET Kanazawa University research: Visualizing how cancer drugs reshape proteins linked to lung cancer
known as EML4–ALK. Drugs that inhibit ALK have dramatically improved patient outcomes, but many patients eventually develop resistance, limiting long-term effectiveness. Until now, it has been difficult to understand this resistance at a molecular level because large parts of the EML4–ALK
More news about: Kanazawa University
Dec 23, 2025, 08:32 ET Pusan National University Researchers Uncover Scalable Method for Ultrahigh-Resolution Quantum Dot Displays
method for QD patterning. Instead of exposing QDs to harsh chemical modifications, the team engineered a photocrosslinkable blended emissive layer (b-EML). This layer is formed by mixing QDs with a hole-transport polymer and a small fraction of an ultraviolet (UV)-activated crosslinker, enabling precise
More news about: Pusan National University
Dec 18, 2025, 01:09 ET Благодаря прецизионной онкологии 69-летняя пациентка из Казахстана возвращает свою жизнь, принимая ежедневно одну таблетку
опухолевая ткань пациентки подверглась комплексному геномному профилированию. Комплексное геномное профилирование тканевого образца выявило слияние EML4-ALK, аномалию генов с предсказуемым ответом на таргетную терапию. Вместо химиотерапии или лучевой терапии ей назначали таргетную терапию, заключающуюся
More news about: Apollo Athenaa
Dec 18, 2025, 01:08 ET 69-Year-Old Patient from Kazakhstan Reclaims Her Life with a Single Daily Pill Through Precision Oncology
Following a biopsy, her tumour tissue underwent comprehensive genomic profiling. Comprehensive genomic profiling of the tissue biopsy identified an EML4-ALK fusion, an alteration predictive of response to targeted therapy. Instead of chemotherapy or radiotherapy, she was placed on a targeted therapy
More news about: Apollo Athenaa
Nov 13, 2025, 13:37 ET MiBA Expands Support for Value-Based Cancer Care Through Partnership with American Oncology Network
https://www.prnewswire.com/news-releases/evolent-and-american-oncology-network-unveil-innovative-model-seeking-to-improve-cancer-care-while-eliminating-prior-authorization-burden-302607605.html?tc=eml_cleartime About
More news about: MiBA
Oct 28, 2025, 07:00 ET Genprex Collaborators Report Positive Preclinical Data on the Use of Reqorsa® Gene Therapy for the Treatment of Lung Cancer at the 2025 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
its own as well as when combined with other therapies in a mouse xenograft model with ALK-EML4 rearrangement. The combination of REQORSA and an ALK inhibitor led to longer survival in the mouse model. ALK-EML4 rearrangements occur in approximately 4% of all patients with NSCLC. We believe these positive
More news about: Genprex, Inc.
Oct 23, 2025, 07:00 ET Genprex Collaborators to Present Positive Preclinical Data on the Use of Reqorsa® Gene Therapy for the Treatment of Lung Cancer at the 2025 AACR-NCI-EROTC International Conference on Molecular Targets and Cancer Therapeutics
Reqorsa® Gene Therapy is a Potential Treatment for ALK-EML4 Positive Translocated Non-Small Cell Lung Cancer Research Suggests that REQORSA May Be an Effective Treatment
More news about: Genprex, Inc.
Oct 14, 2025, 07:00 ET Genprex Collaborators to Present Positive Preclinical Data on the Use of Reqorsa® Gene Therapy for the Treatment of Lung Cancer at the 2025 AACR-NCI-EROTC International Conference on Molecular Targets and Cancer Therapeutics
Reqorsa® Gene Therapy is a Potential Treatment for ALK-EML4 Positive Translocated Non-Small Cell Lung Cancer AUSTIN, Texas, Oct.
More news about: Genprex, Inc.
Oct 08, 2025, 08:00 ET Wall Street Prep, Financial Edge, and Euromoney Learning Combine to Create Global Leader in Financial Training
Oct. 8, 2025 /PRNewswire/ -- Wall Street Prep ("WSP"), Financial Edge Training ("FE"), and Euromoney Learning ("EML"), three of the most respected names in financial education, today announced they are combining to create the world's premier platform for finance training.
More news about: Wall Street Prep
Oct 08, 2025, 08:00 ET Wall Street Prep, Financial Edge, and Euromoney Learning Combine to Create Global Leader in Financial Training
Oct. 8, 2025 /PRNewswire/ -- Wall Street Prep ("WSP"), Financial Edge Training ("FE"), and Euromoney Learning ("EML"), three of the most respected names in financial education, today announced they are combining to create the world's premier platform for finance training.
More news about: Wall Street Prep
Sep 12, 2025, 09:25 ET WFH mobilizes global community to achieve milestone revisions to WHO EML
The revisions introduced in the recently published 24th EML and 10th EMLc will help to increase equitable access to safer and more effective therapies for PWBDs worldwide. Outlined below are the critical changes made to the EML and EMLc, in relation to the medicines indicated for treatment of
More news about: World Federation of Hemophilia
Sep 12, 2025, 09:17 ET WFH mobilizes global community to achieve milestone revisions to WHO EML
The revisions introduced in the recently published 24th EML and 10th EMLc will help to increase equitable access to safer and more effective therapies for PWBDs worldwide. Outlined below are the critical changes made to the EML and EMLc, in relation to the medicines indicated for treatment of
More news about: World Federation of Hemophilia
Jul 30, 2025, 08:00 ET Coinstar Names Brandon Thompson as CCO To Accelerate Digital Transformation and Product Expansion
he led product, marketing, and commercial strategy across prepaid and mobile financial services. He also held senior executive roles at Netspend and EML, helping to scale product portfolios that gave millions of cash-reliant consumers access to digital tools. To learn more about Coinstar, visit
More news about: Coinstar
Jul 23, 2025, 16:41 ET AdvisorVault Offers 17a-4 Gap Assessment Free, Getting FINRA Firms Compliant on Microsoft 365
records?FINRA Compliant Are advanced searches enabled with keyword flagging & download sample sets from the cloud in zip, pst , eml formats on demand?
More news about: AdvisorVault
Jul 23, 2025, 09:00 ET Lucid Launches Collaborative with Critical Minerals Producers to Further Strengthen Supply Chain for American Automotive and EV Manufacturing
improve battery life and reduce reliance on other metals such as cobalt. Electric Metals USA (TSXV: EML) (OTCQB: EMUSF) Limited is currently developing the Emily manganese project in Minnesota.
More news about: Lucid Group
Jul 22, 2025, 10:50 ET Hadrius Introduces Client Trade Surveillance -- Enterprise-Scale Monitoring for Managed Accounts, Powered by Zero Data Retention AI
and triggering rules for defensible closure.Audit-Ready Reporting & Exports – Live dashboards plus one-click regulator packs (CSV/EML/PDF) streamline exam response cycles.Zero Data Retention AI with OpenAI (Hadrius Differentiator) – Stateless inference: surveillance
More news about: Hadrius
Jun 17, 2025, 09:30 ET Lung Cancer Research Foundation Announces Request for Proposals Focused on Curing EGFR Mutant Lung Cancers
drivers that were successfully targeted with the use of tyrosine kinase inhibitors (TKIs). Subsequently additional oncogenic driver alterations in EML4-ALK, BRAF, RET, KRAS G12C, HER2, MET, NTRK, ROS1 and NRG1 were identified along with corresponding therapeutic options for treatment. Several TKIs including
More news about: Lung Cancer Research Foundation